Cognoa moves ahead on FDA clearance of digital autism diagnostic

By Meg Bryant Children with autism spectrum disorder (ASD) can face a lifetime of frustration because of challenges with communication, social behaviors and flexibility of thought. Early intervention can improve outcomes, but nailing a diagnosis of ASD often takes years. Cognoa Inc. wants to change that with its digital ASD Diagnostic and is on track to apply for U.S. FDA clearance before the…

This AI Tool For Diagnosing Autism Could Hit The Market ‘In The Second Half Of 2021’

Graison Dangor Contributor Healthcare I cover the intersection of mental health, the economy, and policy. A tool that helps pediatricians diagnose autism with artificial intelligence and smartphone video passed a key FDA test and could hit the market as soon as next summer, according to device-maker Cognoa, which recently announced its plans to submit the tool for final approval. In…

Autism: Awareness, Acceptance, Action

By: Lani Hessen, Director of Advocacy, Cognoa, and Pediatric Occupational Therapist (OTR/L) Autism impacts an estimated 1 in 54 children in the U.S. today. Autism is a spectrum, representing a tremendous range of skills and challenges spanning learning and communication, socialization and developmental behaviors.  Autism impacts children and families of all backgrounds, regardless of race, ethnicity, location, or wealth. As…

Earlier diagnosis and more
effective treatments.